Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells.

Čapoun, Otakar

Prognosis of Castration-resistant Prostate Cancer Patients - Use of the AdnaTest® System for Detection of Circulating Tumor Cells. [electronic resource] - Anticancer research Apr 2016 - 2019-26 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1791-7530


Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Docetaxel
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplastic Cells, Circulating
Prognosis
Prostate-Specific Antigen--blood
Prostatic Neoplasms, Castration-Resistant--blood
Reverse Transcriptase Polymerase Chain Reaction
Taxoids--therapeutic use
Treatment Outcome